MedPath

Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer.

Not yet recruiting
Conditions
Breast Cancer
Registration Number
NCT06174571
Lead Sponsor
Assiut University
Brief Summary

This work aims to:

1. Evaluation of the role of pregnancy associated plasma protein A( PAPPA ) in diagnosis \& early detection of breast cancer.

2. Evaluation of the relationship between ( PAPPA ) levels and stages of breast cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • female patients with breast cancer who were diagnosed by histopathological studies and did not receive any treatment.
Exclusion Criteria
  • Patients who received chemotherapy or radiotherapy.
  • Patients with known other organ malignancy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quantitative measurement of pregnancy associated plasma protein A in female patients with breast cancer.baseline

Quantitative measurement of pregnancy associated plasma protein A in female patients with breast cancer.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath